Breast cancer advocates a visible presence in San Antonio

Article

This year's Alamo Breast Cancer Foundation (ABCF) advocates come from across the US and around the world. For the next week, the advocates, 30 women and one man, will attend the sessions of the San Antonio Breast Cancer Symposium (SABCS), the largest international gathering of clinicians and researchers that is held annually in San Antonio the first week of December. Each of the advocates, the vast majority of whom are breast cancer survivors, represents one or more organizations where they work one or more aspects of breast cancer.The ABCF, an all-volunteer organization that is funded through local events and individual donations, provides local outreach, runs a helpline, and represents the needs of women in the halls of the Texas legislature where they have spearheaded legislation to provide protection from discrimination due to genetic information; to cover breast reconstruction after mastectomy; to cover two days in the hospital after mastectomy surgery and to require that insurers cover costs associated with federally approved clinical trials. But being located in the home of SABCS, the foundation has also created a unique program that educates breast cancer advocates so they might take the latest information back to their home groups and serve on national funding boards. Sandi Stanford, president of the board of the foundation and chair of the advocate committee, says in the past 15 years that the advocate program has been in operation, more than 500 advocates have come from 41 states and 11 foreign countries. Each advocate is assigned a specific portion of the presentation as his or her "hot topic," and a CD is created at the end of the symposium on which all advocate reports are compiled. After attending the scientific presentations, advocates go to a mentoring session at day's end when a panel of expert clinician researchers report on the most valuable or intriguing part of the day's research. Advocates can question findings and talk one on one with researchers. Some may question why it's so important to have advocates at a meeting where the presentations are clearly for those who have a medical degree – in other words the material is hard to understand. I think that was the attitude of many of the doctors and researchers in the early years when advocates were present, until they heard the questions coming from women who had clearly researched the topic with a vengeance brought on by a will to live. Now, physicians see the role of the advocates as important, because as one oncologist pointed out, they ask thoughtful questions following oral presentations that would not have been aired by professional attendees. This helps clinicians and scientists see their work from the patient view while building trust and confidence on both sides.This year SABCS advocates will be asking questions, challenging assumptions and asking for more focus on the areas close to their hearts – which for some is metastatic breast cancer.You will be hearing from a number of the advocates and the topics they are covering in these blogs. Follow them, and ask questions to be answered in the Thursday Facebook chat. Also, consider becoming an advocate next year.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content